fingolimod hydrochloride has been researched along with oxidopamine in 2 studies
| Studies (fingolimod hydrochloride) | Trials (fingolimod hydrochloride) | Recent Studies (post-2010) (fingolimod hydrochloride) | Studies (oxidopamine) | Trials (oxidopamine) | Recent Studies (post-2010) (oxidopamine) |
|---|---|---|---|---|---|
| 2,771 | 157 | 2,062 | 8,630 | 6 | 2,407 |
| Protein | Taxonomy | fingolimod hydrochloride (IC50) | oxidopamine (IC50) |
|---|---|---|---|
| Glyceraldehyde-3-phosphate dehydrogenase | Homo sapiens (human) | 8 | |
| DNA repair protein RAD52 homolog | Homo sapiens (human) | 0.779 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, M; Liu, Q; Wood, K; Yang, L; Yang, X; Zhao, P; Zhu, X | 1 |
| Guo, Y; Han, M; Lou, H; Perez, RG; Ren, M; Shi, H; Wei, X; Zhang, X | 1 |
2 other study(ies) available for fingolimod hydrochloride and oxidopamine
| Article | Year |
|---|---|
Neuroprotective effects of fingolimod in mouse models of Parkinson's disease.
Topics: Animals; Cell Line, Tumor; Fingolimod Hydrochloride; Gene Expression Regulation; Humans; Male; Mice; Neuroblastoma; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Receptors, Lysosphingolipid; Rotenone; Sphingosine-1-Phosphate Receptors | 2017 |
FTY720 Attenuates 6-OHDA-Associated Dopaminergic Degeneration in Cellular and Mouse Parkinsonian Models.
Topics: Animals; Disease Models, Animal; Dopaminergic Neurons; Dose-Response Relationship, Drug; Fingolimod Hydrochloride; Humans; Male; Mice; Mice, Inbred C57BL; Nerve Degeneration; Oxidopamine; Parkinsonian Disorders | 2017 |